IPP Bureau
India can lead the “One Earth, One Health” vision, says Minister Mandaviya
By IPP Bureau - March 16, 2023
“One Earth, One Health” vision can become a reality only with active global collaboration where countries don’t think of only themselves, but of collective global outcomes
2654 compounds screened for different activities for GPCR profiling: Dr Jitendra Singh
By IPP Bureau - March 16, 2023
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
Apollo Hospitals crosses the landmark of 10,000+ robotic surgeries
By IPP Bureau - March 16, 2023
Expands robotics to 20+ specialities
Biocorp and HRA Pharma to jointly develop a medical device innovation
By IPP Bureau - March 16, 2023
Biocorp will receive an initial milestone payment this year
PCI Pharma plans Biologics assembly facility in the Midwest
By IPP Bureau - March 16, 2023
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Hydrochloride Capsules USP
By IPP Bureau - March 15, 2023
Cleocin Hydrochloride Capsules market achieved annual sales of approximately US $33.6 million
RTsafe announces first use of its PseudoPatient patient-specific quality assurance process
By IPP Bureau - March 15, 2023
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
Cepheid launches its first manufacturing unit in India
By IPP Bureau - March 15, 2023
The facility has been set up to manufacture tuberculosis testing cartridges
Philips and Gibraltar Health Authority announce 16-year strategic partnership
By IPP Bureau - March 15, 2023
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
LifeSigns raises Pre-Series A
By IPP Bureau - March 15, 2023
A funding to expand operations and provide better patient care
Pfizer acquires Seagen for US$ 43 billion to battle cancer
By IPP Bureau - March 14, 2023
Proposed combination enhances Pfizer’s position as a leading company in oncology
Briefs: Lupin and Alembic
By IPP Bureau - March 14, 2023
Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.
Dr. Lal PathLabs selects Kyndryl for cloud services management
By IPP Bureau - March 14, 2023
Kyndryl's multi-cloud management solution leverages AI-based, cloud-hosted models to provide real-time metrics, events, logs, and traces
Alpla and Inden pharma form joint venture
By IPP Bureau - March 14, 2023
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
Precision appoints John Hubbard, PhD, as Board of Directors Chair
By IPP Bureau - March 14, 2023
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
